Catalyst Wire Dossier Catalyst Wire Dossier

SHEN26 Capsule

· Shenzhen Kexing Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHEN26 Capsule, covering 2023-06-18 to 2023-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19 [Phase 3]

See pricing